Ranitidine hydrochloride (INN) (pronounced /rəˈnɪtɨdiːn/) is a histamine H2-receptor antagonist that inhibits stomach acid production. It is commonly used in treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD). Ranitidine is also used alongside fexofenadine and other antihistamines for the treatment of skin conditions such as hives. Ranitidine HCl is marketed under the brand name Zinetac or Zantac (not to be confused with Zyrtec or Xanax).
| Ranitidine Hydrochloride Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Ranitidine Hydrochloride 75 mg | tablet | oral | 1.0 each | OTC |
| Ranitidine Hydrochloride 300 mg | tablet | oral | 1.0 each | OTC |
| Ranitidine Hydrochloride 150 mg | tablet | oral | 1.0 each | OTC |
| Ranitidine Hydrochloride 150 mg | capsule | oral | 1.0 each | OTC |
| Ranitidine Hydrochloride 300 mg | capsule | oral | 1.0 each | OTC |
| Ranitidine Hydrochloride 25 mg/mL | solution | injectable | 1.0 milliliter(s) | OTC |
| Ranitidine Hydrochloride - | powder | compounding | 100.0 gram(s) | OTC |
| Ranitidine Hydrochloride 15 mg/mL | syrup | oral | 1.0 milliliter(s) | OTC |
ranitidine hydrochloride